Drugs / GB 5001A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07799090 | Aug 2025 → Apr 2026 | — | G2GBio, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GB 5001A | “GB 5001A 280 mg long acting Injection” NCT07799090 ↗ |